Real-world application of surufatinib in the treatment of neuroendocrine tumors: a multi-center retrospective study in China
Abstract Recently, the incidence of neuroendocrine tumors (NETs), characterized by neuroendocrine differentiation, has increased. Their heterogeneous origins and biological behaviors complicate diagnosis and treatment. Surufatinib, a novel oral tyrosine kinase inhibitor with dual anti-angiogenic and...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2025-12-01
|
| Colección: | European Journal of Medical Research |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s40001-025-03567-3 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|